Term
|
Definition
rare form of cancer derived from the mesothelial cells that cover the interior surfaces of the chest and abdominal cavities. |
|
|
Term
|
Definition
a dose that must be exceeded before cancer rates begin to rise. |
|
|
Term
|
Definition
this assumes there is no cancer risk at lower doses followed by a dose-response relationship at higher doses. |
|
|
Term
|
Definition
these inhibit immune function and are give to organ transplant patients to prevent rejection of transplanted organ. |
|
|
Term
polycyclic aromatic hydrocarbon |
|
Definition
diverse group of compounds constructed from multiple, fused benzene rings. |
|
|
Term
|
Definition
cantain a nitroso group (N=O) joined to a nitrogen atom. |
|
|
Term
|
Definition
structurally diverse group of cancer-causing molecules produced by biological organisms, mainly microorganisms and plants. |
|
|
Term
|
Definition
any substance that is capable of causing cancer only after it has been metabolically activated. |
|
|
Term
|
Definition
the oxidation reaction of substances catalyzed by cytochrome P450 into carcinogens. |
|
|
Term
|
Definition
3-membered ring containing an oxygen atom covalently bonded to two carbon atoms. the two carbons are electron deficient so they react with atoms that are electron rich. |
|
|
Term
|
Definition
converts normal cells to a precancerous state. |
|
|
Term
|
Definition
carcinogens that cause gene damage, usually by binding to the DNA. |
|
|
Term
|
Definition
enzyme that plays a key role in one of the cell's normal pathways for controlling cell proliferation. |
|
|
Term
|
Definition
a population of cells derived from a single initial cell by successive rounds of cell division. |
|
|
Term
|
Definition
a chemical that exerts either characteristics of an initiating factor or a promoting factor, but not both. |
|
|
Term
|
Definition
agents exhibiting the potential to cause cancer |
|
|